@article{732dc1c881c84b9e9bca3cf2bfb9985e,
title = "Engineering Chimeric Antigen Receptor T Cells against Immune Checkpoint Inhibitors PD-1/PD-L1 for Treating Pancreatic Cancer",
abstract = "Yang et al. developed armed third-generation PD-L1-targeted ACR/CAR T cells utilizing a PD-1/PD-L1 immune checkpoint axis. Both engineered CAR T cells significantly improved tumor control and survival in models of PD-L1-expressed pancreatic cancers.",
keywords = "ACR, CAR, PD-1, PD-L1, PDAC",
author = "Yang, {Ching Yao} and Fan, {Ming Huei} and Miao, {Carol H.} and Liao, {Yi Jen} and Yuan, {Ray Hwang} and Liu, {Chao Lien}",
note = "Publisher Copyright: {\textcopyright} 2020 The Author(s)",
year = "2020",
month = jun,
day = "26",
doi = "10.1016/j.omto.2020.05.009",
language = "English",
volume = "17",
pages = "571--585",
journal = "Molecular Therapy - Oncolytics",
issn = "2372-7705",
publisher = "Cell Press",
}
